This content is from: Features

South Africa considers pharma patent changes

After several years of relative calm, pharmaceutical patents are in the spotlight again in South Africa, with a new Draft IP Policy launched. Russell Bagnall and Dario Tanziani explain why it has been introduced, and discuss the changes proposed

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.

REQUEST ACCESS

Are you already an Managing IP subscriber? Login here

Instant access to all of our content. Membership Options | One Week Trial

Related